About us
Our mission is to make health data usable for better evidence, decisions, and innovation.
We believe in responsible innovation. We believe that AI can transform healthcare, research, and decision-making only if data can be used safely, ethically, and at scale. That is why we build synthetic data and AI infrastructure that help organizations generate evidence without compromising trust, privacy, or compliance.
What we do
Aindo helps organizations turn sensitive data into reliable evidence, without compromising privacy or control.
Using cutting-edge generative AI, we create high-quality synthetic data that preserves the statistical and clinical value of real-world datasets while protecting personal and sensitive information. This makes it possible to analyze, share, and reuse data for research, innovation, and decision-making with greater speed, security, and confidence.
Our technology empowers teams in healthcare, life sciences, finance, and the public sector to accelerate evidence generation, develop safer AI models, and overcome the bottlenecks caused by restricted or sensitive datasets. By making data secure, compliant, and ready for use, we enable organizations to innovate faster, collaborate more effectively, and build AI applications that are trustworthy, scalable, and ready for real-world impact.
Our story: From research roots to European AI evidence infrastructure
Founded in 2018 at the International School for Advanced Studies (SISSA), Aindo began as a boutique AI lab with a bold vision: making data safely usable for innovation through generative AI and privacy-preserving technologies.
In just a few years, we have evolved into a European leader in synthetic data and AI evidence infrastructure, securing competitive funding, patenting our technology, partnering with leading organizations in healthcare and finance, and becoming the first company in Europe certified under Europrivacy™/® for synthetic data in healthcare.
Today, Aindo helps organizations across Europe unlock the value of sensitive data, accelerate evidence generation, and build trustworthy AI at scale.
2018–2019
The Beginning
- Founded at SISSA (Trieste, Italy)
- Launched as an AI consulting boutique focused on healthcare and finance
2020
Early Recognition
- Selected for the European Data Incubator (1 of 500)
- Joined Oxford's Creative Destruction Lab
- Deployed first proof-of-concepts with clients
2021-2022
Building the Platform
- Launched the first version of our AI evidence infrastructure
- Secured €3M investment to expand R&D
- Partnered with major players in healthcare and finance
2023
Industry Validation
- Closed €6M Series A led by United Ventures
- Granted an Italian patent for our synthetic data technology
- 'Best Startup in Industry' by Fortune Italia
2024–2025
European Leadership
- Selected for the Elevator program (Endeavor)
- Grown to a 25-person team across Trieste and Milan
- First company certified under Europrivacy™/® for synthetic data in healthcare
- Won the EIC Accelerator, securing a €2.1M grant for technology development
Today
- Aindo empowers healthcare and life sciences innovators across Europe to unlock safe, privacy-preserving insights – building AI you can trust.